首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Novel biomimetic tripolymer scaffolds consisting of chitosan, collagen type 1, and hyaluronic acid for bone marrow-derived human mesenchymal stem cells-based bone tissue engineering
【24h】

Novel biomimetic tripolymer scaffolds consisting of chitosan, collagen type 1, and hyaluronic acid for bone marrow-derived human mesenchymal stem cells-based bone tissue engineering

机译:由壳聚糖,1型胶原和透明质酸组成的新型仿生三聚物支架,可用于骨髓来源的人间充质干细胞基骨组织工程

获取原文
获取原文并翻译 | 示例
           

摘要

Human bone marrow-derived mesenchymal stem cells (hMSCs) are an ideal osteogenic cell source for bone tissue engineering (BTE). A scaffold, in the context of BTE, is the extracellular matrix (ECM) that provides the unique microenvironment and play significant role in regulating cell behavior, differentiation, and development in an in vitro culture system. In this study, we have developed novel biomimetic tripolymer scaffolds for BTE using an ECM protein, collagen type 1; an ECM glycosaminoglycan, hyaluronic acid; and a natural osteo-conductive polymer, chitosan. The scaffolds were characterized by scanning electron microscopy (SEM) and swelling ratio. The scaffolds were seeded with hMSCs and tested for cytocompatibility and osteogenic potential. The scaffolds supported cell adhesion, enhanced cell proliferation, promoted cell migration, showed good cell viability, and osteogenic potential. The cells were able to migrate out from the scaffolds in favorable conditions. SEM, alkaline phosphatase assay, and immunofluorescent staining confirmed the differentiation of hMSCs to osteogenic lineage in the scaffolds. In conclusion, we have successfully developed biomimetic scaffolds that supported the proliferation and differentiation of hMSCs. These scaffolds hold great promise as a cell-delivery vehicle for regenerative therapies and as a support system for enhancing bone regeneration. (C) 2014 Wiley Periodicals, Inc.
机译:人类骨髓间充质干细胞(hMSCs)是骨组织工程(BTE)的理想成骨细胞来源。在BTE的背景下,支架是细胞外基质(ECM),可提供独特的微环境,并在体外培养系统中在调节细胞行为,分化和发育中发挥重要作用。在这项研究中,我们开发了一种新型的仿生三聚体支架,用于使用ECM蛋白(1型胶原)的BTE。 ECM糖胺聚糖,透明质酸;以及天然的骨传导聚合物壳聚糖。通过扫描电子显微镜(SEM)和溶胀率表征支架。将支架接种hMSC,并测试其细胞相容性和成骨潜能。支架支持细胞粘附,增强细胞增殖,促进细胞迁移,显示出良好的细胞活力和成骨潜力。细胞能够在有利的条件下从支架中迁移出来。 SEM,碱性磷酸酶测定和免疫荧光染色证实了hMSCs在支架中向成骨谱系的分化。总之,我们已经成功开发了支持hMSCs增殖和分化的仿生支架。这些支架作为再生疗法的细胞传递载体和增强骨骼再生的支持系统具有广阔的前景。 (C)2014威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号